Bavarian Nordic
in transformative acquisition of two commercial vaccines from GlaxoSmithKline
- About us
- What we do
- INVESTORS
Investors
We are committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner
Read more - Careers
Careers
We offer a challenging international working environment in which job satisfaction and personal growth have a high priority.
READ MORE